Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,592 signal articles · 62 in last 24h · 122,609 total before filter · latest 58m ago
62last 24h
1248last 7d
206● bullish (7d)
145● bearish (7d)
205publishers
AllMacro202Earnings420M&A98Regulatory24Product9Analyst10
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Intel (INTC) Moves 18A P Into Risk Production As AI Partnerships Expand
Simply Wall St.67d agobullish
Intel (INTC) Moves 18A P Into Risk Production As AI Partnerships Expand

Intel (NasdaqGS:INTC) has moved its next-generation 18A-P manufacturing process into risk production. The 18A-P process is aimed at advanced AI and data center chips and is designed to be backward compatible for customers. Intel is working with Foxconn on AI infrastructure and with Kontron AG on early edge AI deployments. For investors watching Intel, the shift of 18A-P into risk production is a data point in the company’s attempt to build a foundry business alongside its existing processor...

Bernstein Assigns Outperform Rating to Celsius Holdings (CELH)
Insider Monkey67d agobullish
Bernstein Assigns Outperform Rating to Celsius Holdings (CELH)

Celsius Holdings Inc. (NASDAQ:CELH) is one of the 10 best mid-cap stocks that could double your money. On June 12, Bernstein began its coverage of Celsius Holdings Inc. (NASDAQ:CELH) with a price target of $44. An Outperform rating was assigned on the stock, which offers almost 55% upside based on the projected price target. The […]

H.C. Wainwright Reiterates Buy Rating for Structure Therapeutics (GPCR)
Insider Monkey67d agobullish
H.C. Wainwright Reiterates Buy Rating for Structure Therapeutics (GPCR)

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 10 best mid-cap stocks that could double your money. On June 11, H.C. Wainwright reduced its price target on Structure Therapeutics Inc. (NASDAQ:GPCR) from $100 to $70, which still leads to an adjusted upside potential of more than 61%. The firm upheld its Buy rating on the […]

Is This The Best Time to Buy Broadcom (AVGO)?
Insider Monkey67d agobullish
Is This The Best Time to Buy Broadcom (AVGO)?

We just covered Billionaire Dan Loeb Pivots to AI and Sells Old Economy Stocks: His Top 7 AI Picks. Broadcom Inc. (NASDAQ:AVGO) ranks #7 (see Billionaire Dan Loeb’s Top 5 AI Stock Picks). Billionaire Dan Loeb’s Stake: 50,000 Shares Valued at Approximately $15.48 Million (NEW Position) AVGO is down about 10% over the past month […]

Bitcoin Whale Pays Price For Borrowing Binge As Buying Power Flags
Investor's Business Daily67d agobullish
Bitcoin Whale Pays Price For Borrowing Binge As Buying Power Flags

Strategy faces three near-term negative catalysts, all tied to more share issuance that's likely to act as a headwind for MSTR stock. Meanwhile, the bitcoin price staged a modest recovery after sinking to a nearly 19-month low around $60,000 in early June. First, Strategy has interest and dividend payments due at the end of June that should total around $230 million.